Sitagliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes. The Food and Drug Administration has given Biocon Ltd.’s wholly owned ...

Adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes who are not adequately controlled on metformin or sitagliptin alone or in patients already being treated with ...

Unichem has obtained tentative approval from the Food and Drug Administration for sitagliptin tablets in dosage strengths of 25 mg, 50 mg, and 100 mg The medication is a generic of Merck Sharpe and ...

Merck Receives Positive CHMP Opinion for JANUVIA® (sitagliptin) and JANUMET® (sitagliptin/metformin) as Add-On to Insulin in the European Union WHITEHOUSE STATION ...

Do not use if you have ever had an allergic reaction to SITAGLIPTIN MYLAN or any of the ingredients listed at the end of the CMI. Talk to your doctor if you have any other medical conditions, take any ...

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the primary results of the Trial Evaluating Cardiovascular Outcomes with ...

First combination drug to treat type 2 diabetes and high cholesterol in one tablet The U.S. Food and Drug Administration today approved Juvisync (sitagliptin and simvastatin), a fixed-dose combination ...

The diabetes drug sitagliptin appears to reduce the severity of reactive hypoglycemia, a form of low blood sugar that occurs after a meal, a preliminary study finds. The results will be presented ...

Merck concerned for diabetes patients in B.C., in light of B.C. Pharmacare announcement of decision to de-list sitagliptin products (Januvia® and Janumet®) VANCOUVER, Aug. 5, 2014 (Canada NewsWire via ...

ICICI Prudential Asset Management Company is aiming for a valuation of up to 1.07 trillion rupees ($11.90 billion) in its initial public offering, according to a filing on Sunday, and has set a price ...

Objective: To evaluate attainment of diabetes-related quality measures with canagliflozin 100 mg, canagliflozin 300 mg, and sitagliptin 100 mg in patients with type 2 diabetes mellitus. Study design: ...